Abstract
Reply to phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have